Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +1.59% | +0.95% | -0.62% |
Mar. 08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 08 | Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562 | MT |
Financials (USD)
Sales 2024 * | 12.32M | Sales 2025 * | 48.56M | Capitalization | 226M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -19M | EV / Sales 2024 * | 18.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.66 x |
P/E ratio 2024 * |
-4.59
x | P/E ratio 2025 * |
-13.6
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.01% |
Latest transcript on Ovid Therapeutics Inc.
1 day | +1.59% | ||
1 week | +0.95% | ||
Current month | +4.92% | ||
3 months | -5.88% | ||
6 months | -10.11% | ||
Current year | -0.62% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 18-12-31 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 17-06-13 |
Bart Friedman
BRD | Director/Board Member | 79 | 15-11-22 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 3.2 | +1.59% | 110,579 |
24-04-22 | 3.15 | -2.48% | 205,940 |
24-04-19 | 3.23 | +0.62% | 176,642 |
24-04-18 | 3.21 | +3.22% | 226,932 |
24-04-17 | 3.11 | -1.89% | 160,465 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.62% | 226M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+1.66% | 22.19B | |
-16.16% | 21.33B | |
-6.82% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- OVID Stock